Exponent, Inc. (NASDAQ:EXPO) Lowered to “Hold” at Zacks Investment Research

Zacks Investment Research cut shares of Exponent, Inc. (NASDAQ:EXPO) from a buy rating to a hold rating in a research note issued to investors on Friday, June 30th.

According to Zacks, “Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. “

Other equities research analysts have also issued research reports about the company. Cantor Fitzgerald reaffirmed an overweight rating and set a $69.00 price target (up previously from $64.00) on shares of Exponent in a research report on Saturday, April 22nd. BidaskClub lowered Exponent from a hold rating to a sell rating in a research report on Tuesday, June 20th.

Shares of Exponent (NASDAQ:EXPO) traded down 1.00% during trading on Friday, hitting $64.55. The stock had a trading volume of 77,124 shares. Exponent has a 1-year low of $48.42 and a 1-year high of $68.30. The firm has a 50 day moving average of $60.12 and a 200 day moving average of $59.32. The company has a market capitalization of $1.71 billion, a price-to-earnings ratio of 33.46 and a beta of 0.60.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Tuesday, July 18th. The business services provider reported $0.51 EPS for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.10. The company had revenue of $84.10 million for the quarter, compared to analyst estimates of $79.30 million. Exponent had a return on equity of 16.52% and a net margin of 15.94%. Exponent’s revenue was up 14.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.38 earnings per share. Analysts expect that Exponent will post $1.97 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This article was published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this article on another site, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://www.chaffeybreeze.com/2017/07/28/exponent-inc-nasdaqexpo-downgraded-by-zacks-investment-research-to-hold-updated-updated-updated.html.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 22nd. Stockholders of record on Friday, September 1st will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date is Wednesday, August 30th. Exponent’s dividend payout ratio is currently 43.52%.

In related news, insider Sally Shepard sold 1,255 shares of Exponent stock in a transaction that occurred on Friday, July 21st. The stock was sold at an average price of $65.37, for a total value of $82,039.35. Following the sale, the insider now owns 1,560 shares of the company’s stock, valued at approximately $101,977.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider John Pye sold 3,600 shares of Exponent stock in a transaction that occurred on Monday, July 24th. The shares were sold at an average price of $65.08, for a total value of $234,288.00. Following the completion of the sale, the insider now directly owns 14,767 shares in the company, valued at approximately $961,036.36. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of EXPO. State of Alaska Department of Revenue raised its position in Exponent by 0.7% in the first quarter. State of Alaska Department of Revenue now owns 2,830 shares of the business services provider’s stock valued at $168,000 after buying an additional 20 shares during the period. Bank of Montreal Can raised its position in Exponent by 0.7% in the second quarter. Bank of Montreal Can now owns 3,231 shares of the business services provider’s stock valued at $189,000 after buying an additional 22 shares during the period. Miles Capital Inc. raised its position in Exponent by 1.8% in the first quarter. Miles Capital Inc. now owns 3,824 shares of the business services provider’s stock valued at $228,000 after buying an additional 67 shares during the period. UBS Group AG raised its position in Exponent by 0.3% in the first quarter. UBS Group AG now owns 36,673 shares of the business services provider’s stock valued at $2,184,000 after buying an additional 98 shares during the period. Finally, Louisiana State Employees Retirement System raised its position in Exponent by 1.0% in the first quarter. Louisiana State Employees Retirement System now owns 10,400 shares of the business services provider’s stock valued at $619,000 after buying an additional 100 shares during the period. 90.10% of the stock is currently owned by hedge funds and other institutional investors.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Get a free copy of the Zacks research report on Exponent (EXPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply